AbbVie Inc.

Company Snapshot

Founded: 2013
Entity Type: Public
Employees: 55,000
Region: U.S.
Revenue: $56,334.0 Millions
Revenue Year: 2024
Segment: Hematologic Oncology, Neuroscience, and Eye Care
Headquarter: North Chicago, Illinois, U.S.
Key Geographics: U.S., Europe, Asia-Pacific

Company Overview

AbbVie Inc. is a major pharmaceutical company that offers immunology, hematologic oncology, neuroscience, aesthetics, and eye care products. AbbVie maintains an extensive immunology portfolio across rheumatology, dermatology, and gastroenterology. The company operates in over 70 countries and markets its products in over 175 countries.

AbbVie has more than 250 collaborations/partnerships with leading biotechnology companies, universities, nonprofits, and government organizations to advance science. The company specializes in monoclonal antibodies, antibody-drug conjugates, and multi-specific antibodies for antibody therapeutics.

AbbVie Inc. In Reports

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

BCC Research expert says the Therapies for Rheumatoid Arthritis market report analyzes the market trends of therapies for rheumatoid arthritis with data from 2024, estimates from 2025, projections of CAGR through 2030. ...

Tissue Engineering and Regeneration: Technologies and Global Markets

Our Research report provides an overview of the Tissue Engineering and Regeneration market and analyzes trends It includes global revenue ($ Million) for the base year of 2024 and estimated data for 2025 and the...

Anti-Parkinson's Drugs: Global Markets to 2030

BCC Research Market Analyst says global market for anti-Parkinson’s drugs is projected to grow from $6.1 billion in 2025 to reach $9.2 billion by the end of 2030, at a CAGR of 8.6%.

Applications/End User Industries

  • Healthcare Providers
  • Hospitals
  • Pharmacies
  • Patients
  • Governments
  • Pharmaceutical
AI: Your Say